- Periplocin
-
- $30.00 / 1mg
-
2026-01-24
- CAS:13137-64-9
- Min. Order:
- Purity: 99.74%
- Supply Ability: 10g
- Periplocin
-
- $0.00 / 20mg
-
2023-02-24
- CAS:13137-64-9
- Min. Order: 5mg
- Purity: ≥98%(HPLC)
- Supply Ability: 10 g
- periplocin
-
- $9.80 / 1KG
-
2020-02-11
- CAS:13137-64-9
- Min. Order: 1g
- Purity: ＞98%
- Supply Ability: 20 tons
|
| | Periplocoside Basic information |
| Product Name: | Periplocoside | | Synonyms: | Periplocoside;3β-[(4-O-β-D-Glucopyranosyl-3-O-methyl-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-5β,14β-card-20(22)-enolide;Periplocin;Card-20(22)-enolide, 3-[(2,6-dideoxy-4-O-β-D-glucopyranosyl-3-O-methyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-, (3β,5β)-;4-((3S,5S,8R,9S,10R,13R,14S,17R)-5,14-Dihydroxy-3-(((2R,4S,5R,6R)-4-methoxy-6-methyl-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one;Periplocin, 10 mM in DMSO | | CAS: | 13137-64-9 | | MF: | C36H56O13 | | MW: | 696.82 | | EINECS: | | | Product Categories: | | | Mol File: | 13137-64-9.mol |  |
| | Periplocoside Chemical Properties |
| Melting point | 205°C | | Boiling point | 610.7°C (rough estimate) | | alpha | D20 +32° | | density | 1.1241 (rough estimate) | | refractive index | 1.7500 (estimate) | | storage temp. | under inert gas (nitrogen or Argon) at 2-8°C | | solubility | DMSO : 250 mg/mL (358.77 mM; Need ultrasonic) | | form | powder | | pka | 12.89±0.70(Predicted) | | color | White | | Water Solubility | 7.937g/L(cold water) | | InChIKey | KWBPKUMWVXUSCA-WVOVULELNA-N | | SMILES | O1CC(=CC1=O)[C@@H]2[C@@]3([C@@](C4C([C@@]5([C@@](C[C@H](CC5)O[C@@H]6OC([C@H](C(C6O)OC)O)CO[C@H]7C(O[C@@H](CC7O)O)C)(CC4)O)C)CC3)(CC2)O)C |
| WGK Germany | WGK 3 | | Storage Class | 6.1A - Combustible acute toxic Cat. 1 and 2
very toxic hazardous materials | | Hazard Classifications | Acute Tox. 2 Inhalation
Acute Tox. 2 Oral
STOT RE 2 | | Toxicity | LD in rabbits, rats (mg/kg): 10, 480 s.c. (MacKeith) |
| | Periplocoside Usage And Synthesis |
| Chemical Properties | Soluble in methanol and DMSO Derived from Periploca odorifera | | Uses | Periplocin can be used to improve bone health to prevent, alleviate, or treat osteoporosis. | | in vivo | Periplocin (5-20 mg/kg; intraperitoneal injection; daily; for 14 days; female SCID mice) treatment represses the growth of hepatocellular carcinoma (HCC) in xenograft tumor model in mice[2]. | Animal Model: | Female SCID mice (6-8 weeks old) injected with Huh-7 cells[2] | | Dosage: | 5 mg/kg, 20 mg/kg | | Administration: | Intraperitoneal injection; daily; for 14 days | | Result: | Repressed the growth of hepatocellular carcinoma (HCC) in xenograft tumor model in mice.
|
|
| | Periplocoside Preparation Products And Raw materials |
|